Precision radiation therapy for older patients with advanced solid tumors
Part of Cancer clinical trials.
This trial tests a targeted radiation therapy approach for adults aged 75 and older whose cancer has advanced and standard treatments have stopped working or are not suitable. The goal is to see if this precise radiation can control the tumor with fewer side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 75 years old or older.
- Your cancer must be advanced or spread, and standard treatments have failed, are not tolerated, or are not available.
- You should be generally able to care for yourself (ECOG score 0–3).
- Your liver and kidney function must be within a certain range (tested by blood work).
- You cannot be pregnant or breastfeeding, and you must not have had another cancer in the last 5 years except for certain curable types.
- You must not have serious heart conditions, uncontrolled infections, or immune system problems that would make the treatment unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of low-dose radiation, focused high-dose radiation, and an immunotherapy drug (tislelizumab) for people with large, advanced solid tumors that have not responded to standard treatments.
This trial tests a special type of radiation that delivers a higher dose to the center of the tumor while limiting radiation to nearby healthy organs. It's for people with certain solid tumors that haven't spread widely or have only a few metastases.
This trial tests whether a combination of chemotherapy and radiation can help older adults (70+ years) with pancreatic cancer that hasn't spread and can't be removed surgically. The goal is to control the tumor and improve quality of life without surgery.
This trial tests combining two types of radiation therapy with an immunotherapy drug for people with advanced solid tumors that have spread or come back. The goal is to see if this approach can help when standard treatments have stopped working or aren’t an option.
This trial tests a single, high-dose radiation treatment (guided by MRI) for people whose cancer has spread to up to 3 spots outside the brain or spine. The goal is to shrink these tumors with one session, potentially helping you live longer or feel better with fewer side effects.
This study tests a combination treatment for people with advanced solid tumors that have not responded to standard therapies. It uses a type of radiation therapy (PRaG) together with another treatment, and is specifically looking at people who have a low level of lymphocytes in their blood, which may affect how well the treatment works.
Hear when a new Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.